# Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes

> **NCT00924053** · PHASE1 · COMPLETED · sponsor: **Theracos** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** EGT0001474
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00924053
- **Lead sponsor:** Theracos
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924053, "Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00924053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*